P. V. Arbekov

P. V. Arbekov

Auto-generated profile, based on publicly available information

P. V. Arbekov

Kirov Military Medical Academy

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2026 in EMERGENCY MEDICAL CARE
Verified
Journal Article
Open access
PDF file
ANA. M. Nosov
A. M. Nosov
KGK. P. Golovko
K. P. Golovko
KDK. N. Demchenko
K. N. Demchenko
EVE. S. Voronov
E. S. Voronov
PAP. V. Arbekov
P. V. Arbekov
Objective . To evaluate the effectiveness of kaolinbased local hemostatic agents for temporary control of external bleeding in emergency medical care. Materials and methods . The study utilized the local hemostatic agent «Kaolin Hemostatic Bandage QuikMed» (Sigmafarm LLC, Russia). Effectiveness was assessed in patients with ongoing external bleeding requiring the use of a tourniquet. The local hemostatic agents were applied by emergency medical teams in Belgorod and Donetsk. The study included patients with uncontrolled ongoing arterial or mixed bleeding, extensive soft tissue wounds with a complex wound channel. Patients with superficial venous bleeding and minor bleeding that could be controlled by a pressure dressing were excluded. Results . The study included 23 patients showing signs of ongoing external bleeding. Among them, 7 cases of arterial, 1 case of venous, and 15 cases of mixed bleeding were recorded. Anatomical locations of arterial bleeding included the arm (1 case), thigh (4 cases), lower leg (1 case), and supraclavicular area (1 case). In 100% of cases, the use of the kaolinbased local hemostatic agent achieved temporary hemostasis, effectively preventing re-bleeding during transportation. Data analysis showed that the effectiveness of the kaolin-b ased local hemostatic agent was statistically comparable to that of chitosan-b ased local hemostatic agent (P≥0.05). Conclusion . Kaolin-b ased local hemostatic agents demonstrated high effectiveness in achieving rapid temporary hemostasis in the pre-hospital setting. The ability to stop bleeding when a tourniquet cannot be used makes them an important and practical tool for emergency medical teams. Owing to their ease of use and reliability, these agents can be considered a promising component of emergency care standards for external bleeding.

5 March 2025 in Plastic Surgery and Aesthetic Medicine
Verified
Journal Article
Closed access
NKN.P. Korableva
N.P. Korableva
NRN.S. Romanenkov
N.S. Romanenkov
DKD.I. Kremlev
D.I. Kremlev
AKA.V. Kosulin
A.V. Kosulin
ANA.A. Nekrasov
A.A. Nekrasov
PAP.V. Arbekov
P.V. Arbekov
Objective. To estimate the efficacy of botulinum toxin type A in prevention of hypertrophic and keloid skin scars. Material and methods. Experimental animals were 3 rabbits Soviet Chinchilla breed. Five ellipsoid wounds were inflicted and then sutured on the outer surface of each ear. The right ear was control, and the left ear was experimental. After 7 days, 2 units of botulinum toxin type A were injected into the scars on the experimental ear. At the control points (14, 28, 42 days), scars were assessed visually. Biopsy was performed with assessment of fibroblasts and myofibroblasts. Results. Visual assessment of scars in the control group revealed hypertrophic scars in 4 out of 15 cases. In the experimental group, no hypertrophic scars were detected. In 42 days after botulinum toxin type A injection, there were fewer fibroblasts in the experimental group (p=0.01). The number of myofibroblasts in scar tissue of experimental animals in 14, 28 and 42 days after botulinum toxin type A injection was 2 times lower than in the control group (p=0.000003). Conclusion. Botulinum toxin type A is effective for prevention of hypertrophic and keloid scars due to its effect on fibroblasts and myofibroblasts.